- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03021096
Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia (TSA Pain)
April 12, 2022 updated by: Hospital for Special Surgery, New York
This study aims to identify the timeline of pain following total shoulder replacement with the goal of developing data for a subsequent randomized trial.
The investigators believe that with using HSS's current protocol, many patients have postoperative pain that is no worse than their preoperative pain.
Previous HSS anesthesia protocols for total shoulder arthroplasty patients have not formally followed patients past their hospital discharge, and the investigators believe that some patients do experience moderate to severe subacute postoperative pain.
Therefore, this study's primary outcome is to look at the numeric pain scores at 14 days after surgery.
Future studies will look at measures of preventing bruising and subsequent pain after shoulder replacement.
Study Overview
Detailed Description
This is a pilot study, with the goals of
- developing data for a subsequent randomized trials
- describing the pain trajectory after total shoulder arthroplasty given comprehensive multimodal perioperative analgesia
- gathering preliminary data about which shoulder arthroplasty patients are at high risk for moderate or severe postoperative pain (NRS with movement, POD14, moderate >= 4- 6; Gerbershagen 2011; severe >= 7-10, Krebs 2007) Potential factors include fibromyalgia score, catastrophizing score, anxiety/depression score, gender, preoperative opioid use
- gathering preliminary data on the potential association between the predictors listed in (c) and NRS pain score with movement on POD 14.
- estimating incidence and severity of postoperative bruising on POD 14
Study Type
Observational
Enrollment (Actual)
108
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- Hospital for Special Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing TSA for Osteoarthritis, Reverse, Anatomic procedures
Description
Inclusion Criteria:
- All patients eligible for the standardized anesthetic for TSA
- Patients who are capable to provide informed consent and answer questions in English (Study involves questionnaires validated in English)
- Age 18-80
Exclusion Criteria:
- Incapable to provide informed consent
- Contraindications for regional anesthesia (anticoagulation, infection at injection site)
- Patients undergoing TSA for Trauma or Rheumatoid Arthritis
- Revision TSA (previous non-TSA surgery is not an exclusion)
- Conversion of hemiarthroplasty to TSA
- Planned use of tranexamic acid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NRS Pain Scores
Time Frame: 14 days after surgery for each patient
|
Quantifying patients' pain at a sub-acute time point after surgery
|
14 days after surgery for each patient
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NRS pain with movement and at rest
Time Frame: Days 1, 3, 7 and 3 months after surgery
|
Days 1, 3, 7 and 3 months after surgery
|
|
Opioid and NSAID consumption (in past 24 hours)
Time Frame: Days 1, 3, 7 and 3 months after surgery
|
Days 1, 3, 7 and 3 months after surgery
|
|
Total number of analgesic pills taken
Time Frame: 1 day, 3 days, 7 days, 14 days and 3 months after surgery
|
Other analgesic usage - POD1, POD3, POD7, POD 14, 3 months.
(Number of tablets of other analgesics used in past 24 hours, including acetaminophen, NSAIDs, COX2 inhibitors, gabapentin, pregabalin, muscle relaxants)
|
1 day, 3 days, 7 days, 14 days and 3 months after surgery
|
Opioid Related Symptom Distress Scale
Time Frame: Day 1 after surgery
|
Day 1 after surgery
|
|
Range of Motion
Time Frame: Day 14 after surgery and 3 months after surgery
|
Measure the ability of shoulder movement from 0 to 180 degrees at these follow up visits with the surgeon after surgery.
|
Day 14 after surgery and 3 months after surgery
|
Incidence and Severity of Bruising
Time Frame: Day 14 after surgery and 3 months after surgery
|
Surgeon will determine whether bruising occurred and if so, the size and severity of the bruise
|
Day 14 after surgery and 3 months after surgery
|
Hospital Anxiety and Depression Scale
Time Frame: Day 1 after surgery
|
Day 1 after surgery
|
|
PainOUT Questionnaire
Time Frame: Day 1 and 14 after surgery
|
Included satisfaction question
|
Day 1 and 14 after surgery
|
Pain catastrophizing Scale
Time Frame: Day of Surgery
|
Day of Surgery
|
|
Fibromyalgia Scale
Time Frame: Day of Surgery
|
Day of Surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Goon AK, Dines DM, Craig EV, Gordon MA, Goytizolo EA, Lin Y, Lin E, YaDeau JT. A clinical pathway for total shoulder arthroplasty-a pilot study. HSS J. 2014 Jul;10(2):100-6. doi: 10.1007/s11420-014-9381-0. Epub 2014 Mar 8.
- YaDeau JT, Gordon MA, Goytizolo EA, Lin Y, Fields KG, Goon AK, Holck G, Miu TW, Gulotta LV, Dines DM, Craig EV. Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study. Pain Med. 2016 May;17(5):940-60. doi: 10.1093/pm/pnv010. Epub 2015 Dec 14.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 27, 2017
Primary Completion (ACTUAL)
December 18, 2017
Study Completion (ACTUAL)
March 22, 2018
Study Registration Dates
First Submitted
January 3, 2017
First Submitted That Met QC Criteria
January 11, 2017
First Posted (ESTIMATE)
January 13, 2017
Study Record Updates
Last Update Posted (ACTUAL)
April 14, 2022
Last Update Submitted That Met QC Criteria
April 12, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-0779
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on Surveys
-
Memorial Sloan Kettering Cancer CenterCompletedRectal Cancer | Colon CancerUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting
-
RANDClaremont Graduate UniversityCompleted
-
Elysium HealthUniversity of OxfordNot yet recruitingBiological Aging
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedMuscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IVUnited States
-
University Hospital, AngersCompletedOpioid-Related Disorders | Critically Ill | Pain, ChronicFrance
-
Mayo ClinicCompletedCesarean SectionUnited States
-
Northwestern UniversityCompleted
-
Richmond University Medical CenterRecruiting